TriSalus Life Sciences, Inc.
TriSalus Life Sciences, Inc. (NASDAQ: TLSI) is trading at $4.54, about ₹435 at today's USD/INR rate, as of 25 Sep 2026, 1:36 PM ET, down 1.63% today. Indian residents can buy TriSalus Life Sciences from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$4.44
Today's high
$4.61
52 week low
$2.20
52 week high
$7.95
TLSI opened at $4.57, closed previously at $4.61, and has traded between $2.20 and $7.95 over the past 52 weeks.
About
TriSalus Life Sciences, Inc. is an immunotherapy firm dedicated to the research, development, and market introduction of treatments that leverage the body's immune system, primarily targeting liver and pancreatic cancers. The company's product portfolio includes the TriNav Infusion System, designed for hepatic arterial infusion to treat liver tumors, and the Pancreatic Retrograde Venous Infusion System, which addresses pancreatic tumors. Additionally, TriSalus is advancing SD-101, an investigational immunotherapeutic that incorporates pressure-enabled drug delivery technology. This experimental therapy is currently being explored for its application in hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company's operations are headquartered in Westminster, Colorado.
Key statistics
Avg. volume
363.51K
Market cap
$279.24M
P/E Ratio
-3.49
Price-to-sales ratio
6.19
Enterprise value
$267.38M
Free cash flow yield
-10.71%
Debt-to-equity ratio
5.26
Return on equity
273.71%
ROIC
-59.22%
Beta
0.44
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$45.15M
Earnings per share
-$1.84
Free cash flow
-$18.93M
Net profit margin
-62.59%
Gross margin
85.79%
EBITDA
-$33.05M
Revenue growth
53.41%
Similar securities
This is not an investment recommendation
How to buy TriSalus Life Sciences from India
Indian residents can buy TriSalus Life Sciences shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for TriSalus Life Sciences and place an order
Find TriSalus Life Sciences by name or by its ticker, TLSI, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. TriSalus Life Sciences trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your TriSalus Life Sciences position in USD and INR. TriSalus Life Sciences pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in TriSalus Life Sciences from India
Trading and taxes when buying TriSalus Life Sciences from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneTriSalus Life Sciences does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy TriSalus Life Sciences stock?
Yes. TriSalus Life Sciences (TLSI) has been listed on NASDAQ since 2021, in the Medical - Devices industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one TriSalus Life Sciences share cost in rupees?
One TriSalus Life Sciences share is $4.54 — about ₹435 at a USD/INR rate of 96.02 on 24 Sep 2026. Both the TriSalus Life Sciences price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying TriSalus Life Sciences from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of TriSalus Life Sciences?
Yes. One TriSalus Life Sciences share is $4.54, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in TriSalus Life Sciences.
How are gains on TriSalus Life Sciences shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the TriSalus Life Sciences price. Paasa issues a capital-gains statement for your return.
Does TriSalus Life Sciences pay a dividend?
No. TriSalus Life Sciences does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade TriSalus Life Sciences from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on TriSalus Life Sciences shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare TriSalus Life Sciences shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your TriSalus Life Sciences holding, its cost and its closing value.
How do I sell TriSalus Life Sciences and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.